Rafael Rosengarten, Ph.D., is CEO and Co-founder of Genialis. Rafael leads Genialis’ effort to realize the promise of precision medicine. Prior to Genialis, he spent nearly 20 years in biomedical research, publishing on the evolution of innate immune systems, bioengineering of microbes, and genetics of development. Rafael co-invented the j5 DNA assembly design automation software for high-throughput molecular design and analyses (since commercialized by TeselaGen). Rafael earned his doctorate at Yale University, and conducted his postdoctoral research at Lawrence Berkeley National Laboratory, Joint BioEnergy Institute (JBEI) and Baylor College of Medicine.